1140.HK stock is climbing in pre-market trading on the Hong Kong Stock Exchange. HK.AI Capital Limited, trading under the symbol 1140.HK, gained 1.96% to reach HK$0.208 per share as of April 15, 2026. The stock opened at HK$0.216 with a day range between HK$0.194 and HK$0.228. Volume surged to 9.72 million shares, significantly above the 9.42 million average. This investment holding company focuses on customized solutions in medical, finance, and technology sectors. Meyka AI’s real-time market analysis platform tracks 1140.HK alongside thousands of global equities for investors seeking data-driven insights.
1140.HK Stock Price Movement and Technical Setup
1140.HK stock opened at HK$0.216 and climbed to a day high of HK$0.228, reflecting solid buying interest in pre-market hours. The stock gained HK$0.004 from the previous close of HK$0.204, translating to the 1.96% gain. Over longer timeframes, 1140.HK has delivered impressive returns: up 9.80% in one day, 16.67% over five days, and 30.23% in the past month. Year-to-date performance stands at 15.46%, while the one-year return reaches 190.91%. The 50-day moving average sits at HK$0.18308, and the 200-day average is HK$0.16394, both below current price levels. This positioning suggests upward momentum. The year-high stands at HK$0.28, while the year-low is HK$0.071, showing the stock has recovered significantly from its lows.
Advertisement
Technical Indicators Show Overbought Conditions
Technical analysis of 1140.HK reveals strong momentum signals mixed with overbought warnings. The Relative Strength Index (RSI) reads 71.27, indicating overbought territory above the 70 threshold. The Stochastic oscillator shows %K at 92.51 and %D at 90.09, both extremely elevated. The Money Flow Index (MFI) registers 96.36, also in overbought range. However, the Average Directional Index (ADX) measures 26.82, confirming a strong trend is in place. The MACD histogram shows positive momentum at 0.01. Bollinger Bands position the price near the upper band at HK$0.21, with the middle band at HK$0.18. These signals suggest the stock has moved sharply higher but may face near-term consolidation or pullback.
Meyka AI Grades 1140.HK with Neutral Recommendation
Meyka AI rates 1140.HK with a grade of B, earning a score of 63.15 out of 100. The rating recommendation is Neutral, suggesting a HOLD stance for current investors. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The detailed breakdown reveals mixed signals: the DCF score is 1 (Strong Sell), ROE score is 2 (Sell), but ROA score is 5 (Strong Buy), and PB score is 5 (Strong Buy). The PE score of 2 suggests the valuation may be stretched. These grades are not guaranteed and we are not financial advisors. The neutral stance reflects balanced risk-reward dynamics for the asset management company.
Valuation Metrics and Financial Health
1140.HK trades at a PE ratio of 22.4, above the Financial Services sector average of 12.27, indicating a premium valuation. The price-to-book ratio stands at 0.234, well below the sector average of 0.95, suggesting the stock trades at a discount to book value. The price-to-sales ratio is 8.14, higher than the sector’s 1.67 average. The company maintains a strong balance sheet with a current ratio of 6.75, far exceeding the sector average of 42.13. Debt-to-equity is just 0.065, indicating minimal leverage. Cash per share reaches HK$0.399, providing a solid liquidity cushion. Market capitalization stands at HK$2.61 billion with 11.66 billion shares outstanding. The company generated EPS of HK$0.01 with a book value per share of HK$0.958.
Market Sentiment: Trading Activity and Liquidation Pressure
Trading activity in 1140.HK shows elevated volume relative to historical averages. The relative volume ratio stands at 1.57, meaning today’s volume is 57% above normal levels. This surge in trading activity often accompanies significant price moves and suggests increased investor interest. The On-Balance Volume (OBV) indicator reads 209.24 million, reflecting cumulative buying pressure. The Awesome Oscillator at 0.02 shows positive momentum, though modest. The Rate of Change (ROC) at 30.99% confirms strong upward price acceleration. No significant liquidation pressure appears evident from the technical setup. The elevated volume combined with positive momentum indicators suggests institutional or retail accumulation rather than panic selling.
Price Forecast and Investment Outlook
Meyka AI’s forecast model projects 1140.HK will reach HK$0.278 within one year, implying 33.7% upside from current levels. The quarterly forecast stands at HK$0.22, suggesting modest near-term consolidation. Over three years, the model projects HK$0.455, and five-year target reaches HK$0.630. These projections represent significant long-term appreciation potential. However, forecasts are model-based projections and not guarantees of future performance. The company’s focus on high-growth sectors including medical, finance, and technology aligns with structural market trends. Track 1140.HK on Meyka for real-time updates and continuous forecast revisions. Investors should monitor quarterly earnings announcements and sector rotation trends affecting asset management valuations.
Final Thoughts
1140.HK stock demonstrates strong pre-market momentum with a 1.96% gain to HK$0.208 on April 15, 2026. The technical setup shows overbought conditions with RSI at 71.27 and elevated volume at 9.72 million shares. Meyka AI assigns a neutral B-grade rating, reflecting balanced fundamentals and valuation concerns. The company’s strong balance sheet, minimal debt, and focus on growth sectors provide a solid foundation. However, the premium PE ratio and overbought technical indicators warrant caution near-term. Meyka AI’s one-year price target of HK$0.278 suggests meaningful upside potential for patient investors. The Financial Services sector backdrop remains supportive, though broader market conditions merit monitoring. Investors should consider their risk tolerance and investment horizon before making decisions on 1140.HK stock.
Advertisement
FAQs
1140.HK trades at HK$0.208 as of April 15, 2026 pre-market, up 1.96% from HK$0.204. Day range: HK$0.194–HK$0.228 with 9.72 million shares traded.
Meyka AI assigns a B grade (63.15 score) with HOLD recommendation, considering sector performance and financial metrics. Ratings are not guaranteed investment advice.
Meyka AI projects HK$0.278 within one year (33.7% upside), HK$0.455 in three years, and HK$0.630 in five years. Forecasts are model-based and not guaranteed.
Yes, technical indicators show overbought conditions: RSI 71.27, Stochastic %K 92.51, MFI 96.36—all above 70. ADX 26.82 confirms a strong uptrend remains intact.
HK.AI Capital Limited operates in Financial Services/Asset Management, developing customized investment solutions targeting high-growth companies in medical, finance, TMT, and health sectors.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)